MX2007003518A - Agentes formadores de imagenes de inhibidor de metaloproteinasa. - Google Patents
Agentes formadores de imagenes de inhibidor de metaloproteinasa.Info
- Publication number
- MX2007003518A MX2007003518A MX2007003518A MX2007003518A MX2007003518A MX 2007003518 A MX2007003518 A MX 2007003518A MX 2007003518 A MX2007003518 A MX 2007003518A MX 2007003518 A MX2007003518 A MX 2007003518A MX 2007003518 A MX2007003518 A MX 2007003518A
- Authority
- MX
- Mexico
- Prior art keywords
- imaging agents
- metalloproteinase inhibitor
- imaging
- inhibitor imaging
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion describe que agentes formadores de imagenes, los cuales comprenden un tipo especifico de inhibidores de metaloproteinasa de matriz (MMPis) de la clase de hidroxamato etiquetados con una porcion formadora de imagenes, son utiles como agentes formadores de imagenes diagnosticos para formacion de imagenes in vivo y diagnostico del cuerpo mamifero.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0421308.8A GB0421308D0 (en) | 2004-09-24 | 2004-09-24 | Enzyme inhibitor imaging agents |
PCT/GB2005/003679 WO2006032911A2 (en) | 2004-09-24 | 2005-09-23 | Metalloproteinase inhibitor imaging agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007003518A true MX2007003518A (es) | 2007-05-18 |
Family
ID=33397228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007003518A MX2007003518A (es) | 2004-09-24 | 2005-09-23 | Agentes formadores de imagenes de inhibidor de metaloproteinasa. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080279769A1 (es) |
EP (1) | EP1796736A2 (es) |
JP (1) | JP2008514580A (es) |
KR (1) | KR20070054690A (es) |
CN (1) | CN101076357A (es) |
AU (1) | AU2005286267A1 (es) |
BR (1) | BRPI0515894A (es) |
CA (1) | CA2579801A1 (es) |
GB (1) | GB0421308D0 (es) |
MX (1) | MX2007003518A (es) |
NO (1) | NO20072120L (es) |
RU (1) | RU2007110372A (es) |
WO (1) | WO2006032911A2 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0610395D0 (en) | 2006-05-25 | 2006-07-05 | Ge Healthcare Ltd | Novel imaging agents |
EP2147684A1 (en) | 2008-07-22 | 2010-01-27 | Bracco Imaging S.p.A | Diagnostic Agents Selective Against Metalloproteases |
CN101654426B (zh) * | 2008-08-18 | 2013-04-17 | 中国人民解放军军事医学科学院毒物药物研究所 | 制备伊洛马司他的方法 |
WO2010065899A2 (en) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof |
US8465725B2 (en) | 2009-06-15 | 2013-06-18 | Molecular Insight Pharmaceuticlas, Inc. | Process for production of heterodimers of glutamic acid |
ES2748940T3 (es) * | 2011-11-11 | 2020-03-18 | Univ Yale | Evaluación de la presencia de una fibrilación auricular y de la vulnerabilidad a ésta, y otras indicaciones sobre la base de la toma de imágenes basada en metaloproteinasas de matriz |
WO2013103813A1 (en) | 2012-01-06 | 2013-07-11 | Molecular Insight Pharmaceuticals | Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase ix |
EP2912464B1 (en) * | 2012-10-24 | 2017-04-26 | Becton Dickinson and Company | Hydroxamate substituted azaindoline-cyanine dyes and bioconjugates of the same |
SG11201505477TA (en) | 2013-01-14 | 2015-08-28 | Molecular Insight Pharm Inc | Triazine based radiopharmaceuticals and radioimaging agents |
US20140271465A1 (en) * | 2013-03-15 | 2014-09-18 | Mallinckrodt Llc | Matrix metalloprotease (mmp) targeted agents for imaging and therapy |
GB202012671D0 (en) * | 2020-08-13 | 2020-09-30 | Nrf Ithemba Labs | Theranostic Compounds |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183900A (en) * | 1990-11-21 | 1993-02-02 | Galardy Richard E | Matrix metalloprotease inhibitors |
US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
US5620675A (en) * | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
ATE181055T1 (de) * | 1994-05-28 | 1999-06-15 | British Biotech Pharm | Succinyl hydroxamsäure-, n-formyl-n-hydroxy- aminocarbonsäure- und succinsäureamid-derivate und ihre verwendung als metalloprotease- inhibitoren |
GB9708265D0 (en) * | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
US6656448B1 (en) * | 2000-02-15 | 2003-12-02 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
US6989139B2 (en) * | 2000-02-15 | 2006-01-24 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
US6673333B1 (en) * | 2000-05-04 | 2004-01-06 | Research Corporation Technologies, Inc. | Functional MRI agents for cancer imaging |
NZ530156A (en) * | 2001-07-10 | 2007-04-27 | Ge Healthcare As | Peptide-based compounds for targeting integrin receptors for use as diagnostic imaging agents |
CA2514885A1 (en) * | 2003-02-10 | 2004-08-19 | Ge Healthcare Limited | Diagnostic imaging agents with mmp inhibitory activity |
-
2004
- 2004-09-24 GB GBGB0421308.8A patent/GB0421308D0/en not_active Ceased
-
2005
- 2005-09-23 EP EP05794106A patent/EP1796736A2/en not_active Withdrawn
- 2005-09-23 MX MX2007003518A patent/MX2007003518A/es unknown
- 2005-09-23 CN CNA2005800399330A patent/CN101076357A/zh active Pending
- 2005-09-23 RU RU2007110372/04A patent/RU2007110372A/ru not_active Application Discontinuation
- 2005-09-23 AU AU2005286267A patent/AU2005286267A1/en not_active Abandoned
- 2005-09-23 US US11/575,977 patent/US20080279769A1/en not_active Abandoned
- 2005-09-23 WO PCT/GB2005/003679 patent/WO2006032911A2/en active Application Filing
- 2005-09-23 CA CA002579801A patent/CA2579801A1/en not_active Abandoned
- 2005-09-23 JP JP2007532966A patent/JP2008514580A/ja not_active Withdrawn
- 2005-09-23 KR KR1020077006701A patent/KR20070054690A/ko not_active Application Discontinuation
- 2005-09-23 BR BRPI0515894-0A patent/BRPI0515894A/pt not_active Application Discontinuation
-
2007
- 2007-04-26 NO NO20072120A patent/NO20072120L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2007110372A (ru) | 2008-10-27 |
JP2008514580A (ja) | 2008-05-08 |
KR20070054690A (ko) | 2007-05-29 |
CN101076357A (zh) | 2007-11-21 |
BRPI0515894A (pt) | 2008-08-12 |
WO2006032911A2 (en) | 2006-03-30 |
AU2005286267A1 (en) | 2006-03-30 |
NO20072120L (no) | 2007-06-22 |
WO2006032911A3 (en) | 2006-08-03 |
CA2579801A1 (en) | 2006-03-30 |
US20080279769A1 (en) | 2008-11-13 |
EP1796736A2 (en) | 2007-06-20 |
GB0421308D0 (en) | 2004-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007003518A (es) | Agentes formadores de imagenes de inhibidor de metaloproteinasa. | |
GB0326546D0 (en) | Inhibitor imaging agents | |
BRPI0507684B8 (pt) | agentes de contraste para imagem de perfusão miocárdica | |
EP1547996A4 (en) | DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES HAVING PRION PROTEIN ACCUMULATION AND METHOD OF MARKING | |
HK1145087A1 (en) | Diagnostic agent | |
HK1107003A1 (en) | Mr imaging method for the discrimination between healthy and tumour tissue | |
ATE439868T1 (de) | Targetingmittel für molekulare bilderzeugung | |
WO2007067920A3 (en) | Imaging method, device and system | |
SG152254A1 (en) | Contrast agents for myocardial perfusion imaging | |
DK1472541T3 (da) | Afbildningsmidler og metoder til at afbilde NAALADase og PSMA | |
TW200514593A (en) | Method and device for enhancing transdermal agent flux | |
IL185501A0 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
IL179441A (en) | Method of measuring the activity of egln enzyme and of identifying an agent that modulates activity of said enzyme | |
EP1848466A4 (en) | MRI CONTRAST AGENTS FOR DIAGNOSIS AND PROGNOSIS OF TUMORS | |
CY1108540T1 (el) | Ταυτοποιηση θεραπευτικων ενωσεων | |
NO20054049D0 (no) | Fremgangsmate for diagnose og behandling. | |
WO2007109733A3 (en) | Diagnostic and prognostic markers and treatment strategies for multiple sclerosis | |
PL374188A1 (en) | Medium for contrast enhancement use for ultrasonic, endoscopic and other medical examinations | |
ATE435657T1 (de) | Therapeutische zubereitung von hochreinem fviia und verfahren zu dessen gewinnung | |
GB0606015D0 (en) | therapeutic agents | |
NO20030115D0 (no) | Kontrastmiddel | |
ATE447417T1 (de) | Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie | |
TW200744645A (en) | Contrast agents for myocardium perfusion imaging | |
WO2004082626A3 (en) | Aromatase inhibitor diagnosis and therapy | |
SE0501670L (sv) | Tubhållare |